Clinical trial

Vaccine Treatment for Hormone Refractory Prostate Cancer

NCT00105053

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-03-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2005-03-01Date precision: month

Registry last updated2020-05-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

HyperAcute-Prostate Cancer VaccineBIOLOGICAL

Sponsors & collaborators

NewLink Genetics Corporationlead sponsor

Mapped research locations

OmahaNebraska, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00105053 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.